CA2762355A1 - Methodes et compositions pour des traitements administres au penis - Google Patents

Methodes et compositions pour des traitements administres au penis Download PDF

Info

Publication number
CA2762355A1
CA2762355A1 CA2762355A CA2762355A CA2762355A1 CA 2762355 A1 CA2762355 A1 CA 2762355A1 CA 2762355 A CA2762355 A CA 2762355A CA 2762355 A CA2762355 A CA 2762355A CA 2762355 A1 CA2762355 A1 CA 2762355A1
Authority
CA
Canada
Prior art keywords
blocker
metabolite
calcium channel
calmodulin
penis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2762355A
Other languages
English (en)
Inventor
Kenneth W. Adams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Kenneth Adams Medicine Professional Corp
Original Assignee
Kenneth W. Adams
Dr. Kenneth Adams Medicine Professional Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kenneth W. Adams, Dr. Kenneth Adams Medicine Professional Corporation filed Critical Kenneth W. Adams
Priority to CA2762355A priority Critical patent/CA2762355A1/fr
Publication of CA2762355A1 publication Critical patent/CA2762355A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA2762355A 2011-12-16 2011-12-16 Methodes et compositions pour des traitements administres au penis Abandoned CA2762355A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2762355A CA2762355A1 (fr) 2011-12-16 2011-12-16 Methodes et compositions pour des traitements administres au penis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2762355A CA2762355A1 (fr) 2011-12-16 2011-12-16 Methodes et compositions pour des traitements administres au penis

Publications (1)

Publication Number Publication Date
CA2762355A1 true CA2762355A1 (fr) 2013-06-16

Family

ID=48652979

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2762355A Abandoned CA2762355A1 (fr) 2011-12-16 2011-12-16 Methodes et compositions pour des traitements administres au penis

Country Status (1)

Country Link
CA (1) CA2762355A1 (fr)

Similar Documents

Publication Publication Date Title
EP0357581B2 (fr) Composition pour le traitement de troubles de l'érection
US5145852A (en) Vaso-active medicament to treat impotence
CA2065270C (fr) Methodes et compositions provoquant l'erection
US9005183B2 (en) System and method for treating erectile dysfunction
Seftel et al. Clozapine-associated priapism: a case report
Chao et al. Experience with intracavernosal tri-mixture for the management of neurogenic erectile dysfunction
KR20010021505A (ko) 발기 부전을 치료하기 위한 요힘빈 및 아르기닌 함유 약제
EP0618798B1 (fr) Composes de pyridylguanidine pour le traitement de dysfonctionnement de l'erection
Sharlip Evaluation and nonsurgical management of erectile dysfunction
US20170087164A1 (en) Method and composition for enhancement of male erectile function
Watters et al. Experience in the management of erectile dysfunction using the intracavernosal self-injection of vasoactive drugs
EP1474143B1 (fr) Methodes et compositions de traitement de dysfonctionnement erectile
US20160101093A1 (en) Methods for the treatment of premature ejaculation
CA2762355A1 (fr) Methodes et compositions pour des traitements administres au penis
Bénard et al. Self-administration in the pharmacological treatment of impotence
Gentili et al. Sexual dysfunction in older adults
RU2475241C1 (ru) Способ лечения острых орхоэпидидимитов и их осложнений
Serrate et al. The usefulness of ethylephrine (Efortil-R) in the treatment of priapism and intraoperative penile erections
AU2013337341B2 (en) Bremelanotide therapy for female sexual dysfunction
WO2000023056A2 (fr) Utilisation d'agents dopaminergiques dans la gestion des dysfonctionnements sexuels
US20090257956A1 (en) Treatment Method for Treatment of Erectile Dysfunction and Premature Ejaculation
Bar-Chama et al. Intracavernosal injection therapy and other treatment options for erectile dysfunction
Armstrong et al. Practical management of erectile dysfunction
Werner New drugs for improving injury outcome in spinal cord injuries.
Campbell Treating erectile dysfunction

Legal Events

Date Code Title Description
FZDE Dead

Effective date: 20171218